LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection.
about
Characterisation and in vitro activities of surface attached dihydropyrrol-2-ones against Gram-negative and Gram-positive bacteria.Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.Bloodstream infections after solid-organ transplantationRisk factors and outcomes of fungal ventricular-assist device infectionsCanadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.Pharmacotherapy for mechanical circulatory support: a comprehensive review.Ventricular assist device infections.Impact of adverse events on ventricular assist device outcomes.Current concepts in the diagnosis and management of left ventricular assist device infections.Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.Left ventricular assist device exchange for persistent infection: a case series and review of the literature.Clinical management for complications related to implantable LVAD use.Prevention and Infection Management in Mechanical Circulatory Support Device Recipients.Development and in vitro evaluation of infection resistant materials: A novel surface modification process for silicone and Dacron.Infectious Complications of Mechanical Circulatory Support (MCS) Devices.Successful heart transplantation in patients with active Staphylococcus bloodstream infection and suspected mechanical circulatory support device infection.Bone-destroying candida infection following left ventricular assist device explant.Left ventricular assist device-related infection: treatment and outcome.Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.
P2860
Q33734723-104746A7-D031-4221-8436-7F4BBFA7595DQ36071675-BC029DDE-B167-4049-B371-E4D02725D14EQ36913353-1423AB75-6471-4C71-96F8-4FF6CC9CD8B0Q37158218-BF20CC35-69E3-41DD-BA78-593E5FC194F3Q37252858-2D039AE1-5CE2-427D-AFE7-C0464298B659Q37826020-CD41B11F-9CAF-4DC2-9471-EAA84D4A283DQ38007865-8C0DA3BD-A22A-4FD8-BBF6-B2D8011A5E50Q38073665-1CCA5C27-D66B-47DC-A64E-1FCCF4AB0BD1Q38081496-084A148B-B4C5-430B-B2A4-6C019BC891E1Q38166459-F2328AE7-F3DB-4D72-A0FF-EA8CDD16F99BQ38202282-EE9E587C-3AF4-48E3-B355-0AAE652DAA83Q38265076-8D28FBA1-A4B5-45DC-9AD4-009D6E025C34Q40406216-12F175FC-009A-43E2-9125-09EB5B9BD8A4Q40894635-EC16A0E7-9700-46C6-9E29-85D470BD1BA0Q42246076-1483F07A-C904-4414-A416-52BF5137ED9AQ46261185-DAA3F43C-8881-40A7-995B-73CD7737CEAFQ50870667-D31C5D99-3BC7-413A-908C-47DA58F7F46BQ51521286-8EDDBAD0-7E69-4EAF-9356-9BBF06C4D960Q55339985-FDF89906-6F62-47F7-826F-D86BA206B6BD
P2860
LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
LVAD bloodstream infections: t ...... antation after LVAD infection.
@en
LVAD bloodstream infections: t ...... antation after LVAD infection.
@nl
type
label
LVAD bloodstream infections: t ...... antation after LVAD infection.
@en
LVAD bloodstream infections: t ...... antation after LVAD infection.
@nl
prefLabel
LVAD bloodstream infections: t ...... antation after LVAD infection.
@en
LVAD bloodstream infections: t ...... antation after LVAD infection.
@nl
P2093
P1476
LVAD bloodstream infections: t ...... antation after LVAD infection.
@en
P2093
Bartley P Griffith
Damian Sorce
Ellieen Stanford
Margaret Wagener
Robert L Kormos
Robert S Poston
Shahid Husain
Shimon Kusne
P304
P356
10.1016/S1053-2498(02)00645-9
P577
2003-08-01T00:00:00Z